Urteste S.A. Logo

Urteste S.A.

Develops non-invasive urine tests for the early detection of multiple cancers.

URT | WAR

Overview

Corporate Details

ISIN(s):
PLURTST00010 (+1 more)
LEI:
259400Q4S6JIKFQHGU06
Country:
Poland
Address:
Gdańsk Starodworska 1, 80-137 Gdańsk

Description

Urteste S.A. is a biotechnology company specializing in the development of non-invasive diagnostic technologies for early cancer detection. The company's core focus is on creating a method to detect multiple types of cancer from a single urine sample. This approach aims to identify malignancies at their earliest stages, potentially improving patient survival rates. The development pipeline includes diagnostic tests for various cancers, with projects such as a prototype for detecting brain tumors and planned clinical trials for a pancreatic cancer test.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-02 14:07
Zawiadomienie
Polish PDF 78.3 KB
2026-01-02 14:07
Zawiadomienie o zmianie stanu posiadania akcji Spółki - Content (PL)
Polish HTML 837 bytes
2025-12-30 15:12
Zestawienie zmian
Polish PDF 153.9 KB
2025-12-30 15:12
Statut Spółki
Polish PDF 568.1 KB
2025-12-30 15:12
Rejestracja podwyższenia kapitału zakładowego i zmian w statucie Spółki - Conte…
Polish HTML 3.4 KB
2025-12-23 15:52
Podsumowanie subskrypcji akcji serii G - Content (PL)
Polish HTML 5.9 KB
2025-12-12 11:38
Zawarcie umów objęcia akcji serii G - Content (PL)
Polish HTML 1.8 KB
2025-12-10 10:57
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Nadzwyczajnym Walnym…
Polish HTML 1.6 KB
2025-12-04 17:00
Podjęte uchwały
Polish PDF 294.0 KB
2025-12-04 17:00
Treść uchwał podjętych podczas obrad Nadzwyczajnego Walnego Zgromadzenia w dniu…
Polish HTML 657 bytes
2025-11-28 08:18
Raport kwartalny 3Q2025
Polish PDF 1.2 MB
2025-11-07 16:00
OPINIA ZARZĄDU uzasadniająca powody pozbawienia akcjonariuszy prawa poboru akcji
Polish PDF 178.5 KB
2025-11-07 16:00
Projekty uchwał
Polish PDF 229.9 KB
2025-11-07 16:00
Pełnomocnictwo udzielane przez osoby prawne do uczestnictwa
Polish PDF 160.7 KB
2025-11-07 16:00
Pełnomocnictwo udzielane przez osoby fizyczne do uczestnictwa
Polish PDF 156.4 KB

Automate Your Workflow. Get a real-time feed of all Urteste S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Urteste S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Urteste S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.